Given the structural similarity between LAG-3 and CD4, major histocompatibility complex class II (MHC II) molecules expressed on antigen-presenting cells (APCs) and tumor cells are the canonical ligands for LAG-3 (27, 37–39). This evidence concerns the gene LAG3 and neoplasm.